List of Perseus Proteomics Inc. patents | 7 results

Name	Description	Patent Applicant	Current Assignee	Patent Jurisdiction	Patent Number	Date of Patent
‌ US Patent 7691586 Method for predicting and judging the recurrence of liver cancer after treating liver cancer	Patent 7691586 was granted and assigned to Perseus Proteomics Inc. on April, 2010 by the United States Patent and Trademark Office.		Perseus Proteomics Inc.	United States Patent and Trademark Office	7691586	April 6, 2010
‌ US Patent 9328160 Anti-CDH3 antibody having high internalization capacity	Patent 9328160 was granted and assigned to Perseus Proteomics Inc. on May, 2016 by the United States Patent and Trademark Office.		Perseus Proteomics Inc.	United States Patent and Trademark Office	9328160	May 3, 2016
‌ US Patent 9513292 Method for diagnosing cancer by detecting GPC3	Patent 9513292 was granted and assigned to Perseus Proteomics Inc. on December, 2016 by the United States Patent and Trademark Office.	Perseus Proteomics Inc.	Perseus Proteomics Inc.	United States Patent and Trademark Office	9513292	December 6, 2016
‌ US Patent 9644028 Anti-CDH3 humanized antibody, drug conjugate thereof, and use thereof	Patent 9644028 was granted and assigned to Perseus Proteomics Inc. on May, 2017 by the United States Patent and Trademark Office.	Perseus Proteomics Inc.	Perseus Proteomics Inc.	United States Patent and Trademark Office	9644028	May 9, 2017
‌ US Patent 9127061 Anti-human P-cadherin (CDH3) recombinant antibody	Patent 9127061 was granted and assigned to Perseus Proteomics Inc. on September, 2015 by the United States Patent and Trademark Office.		Perseus Proteomics Inc.	United States Patent and Trademark Office	9127061	September 8, 2015
‌ US Patent 9764041 Drug conjugate comprising anti-CDH3 (P-cadherin) antibody	Patent 9764041 was granted and assigned to Perseus Proteomics Inc. on September, 2017 by the United States Patent and Trademark Office.		Perseus Proteomics Inc.	United States Patent and Trademark Office	9764041	September 19, 2017
‌ US Patent 11951168 Composition containing buffer	Patent 11951168 was granted and assigned to Perseus Proteomics Inc. on April, 2024 by the United States Patent and Trademark Office.	Perseus Proteomics Inc.	Perseus Proteomics Inc.	United States Patent and Trademark Office	11951168	April 9, 2024